MYLS22 ( —— )

Catalog No. M23118 CAS No. 306959-01-3

MYLS22 is a first-in-class and selective optic atrophy 1 (OPA1) inhibitor.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	32	In Stock
5MG	51	In Stock
10MG	87	In Stock
25MG	149	In Stock
50MG	228	In Stock
100MG	352	In Stock
200MG	528	In Stock
500MG	836	In Stock
1G	Get Quote	In Stock

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

MYLS22
Note

Research use only, not for human use.
Brief Description

MYLS22 is a first-in-class and selective optic atrophy 1 (OPA1) inhibitor.
Description

MYLS22 is a first-in-class and selective optic atrophy 1 (OPA1) inhibitor. MYLS22 can target endothelial OPA1 to curtail tumor growth and inhibits angiogenesis by impinging on NFkB activity and on angiogenic gene expression.
Synonyms

——
Pathway

Others
Target

Other Targets
Recptor

OPA1
Research Area

——
Indication

——

Chemical Information

CAS Number

306959-01-3
Formula Weight

443.5
Molecular Formula

C??H??N?O?S
Purity

>98% (HPLC)
Solubility

DMSO : 50 mg/mL (112.73 mM; ultrasonic and warming and heat to 60°C)
SMILES

——
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Stéphanie Herkenne, et al. Developmental and Tumor Angiogenesis Requires the Mitochondria-Shaping Protein Opa1. Cell Metab. 2020 May 5;31(5):987-1003.e8.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

Product			Quantity Required*
Name *			E-mail Address *
Organization *			Phone Number
Remarks